Pharmaceutical Research

Evidence on efficacy, safety, and who was studied (Type 2 diabetes programme) Introduction When we talk about evidence-based metabolic therapy, the most practical question is often: what did the pivotal…

Insights from Type 2 Diabetes Research and the SURPASS Clinical Programme Introduction The development of incretin-based therapies has transformed the clinical management of obesity and metabolic disorders. Dual incretin receptor…

Clinical and Metabolic Insights from Contemporary Evidence Introduction The growing prevalence of obesity and metabolic disorders has accelerated the development of incretin-based pharmacotherapies. Among these, dual incretin receptor agonist therapies…

Evidence-Based Timeline of Incretin-Driven Weight Loss Introduction In modern metabolic and aesthetic medicine, patients are increasingly interested not only in the effectiveness of therapy, but also in how quickly clinically…

Introduction The management of excess body weight has evolved significantly over the past decade, with incretin-based therapies becoming a central focus in evidence-driven metabolic medicine. Among these approaches, dual incretin…